Medicomp, Inc.

Test & Measurement

Ambulatory AF Burden Monitor helps cardiac patients.

Atrial Fibrillation (AF) burden statistical package, available on ambulatory cardiac monitor, accurately assesses severity of patient's AF over extended period. It uses beat-to-beat independent and concurrent analysis of rate, rhythm, morphology, and p-wave abnormalities to automatically capture symptomatic and asymptomatic AF episodes. Patients can wear discreet monitor for days or weeks, before...

Read More »
Mergers & Acquisitions

Medicomp, Inc. Announces Company Purchase from United Therapeutics

MELBOURNE, Fla., April 5, 2011 -- Medicomp Inc., previously a wholly-owned subsidiary of United Therapeutics Corporation, announced today that it has been acquired by an investment group made up of current and past Medicomp management led by Dan Balda, MD, Medicomp's President and CEO. The sale was finalized on March 31, 2011 and will allow the new Medicomp organization to focus on growing the...

Read More »
Test & Measurement

Ambulatory AF Burden Monitor helps cardiac patients.

Atrial Fibrillation (AF) burden statistical package, available on ambulatory cardiac monitor, accurately assesses severity of patient's AF over extended period. It uses beat-to-beat independent and concurrent analysis of rate, rhythm, morphology, and p-wave abnormalities to automatically capture symptomatic and asymptomatic AF episodes. Patients can wear discreet monitor for days or weeks, before...

Read More »

All Topics